LON:SN - Smith & Nephew Share Price, Forecast & News

Smith & Nephew trades on the London Stock Exchange (LON) under the ticker symbol "SN."

Smith & Nephew announced a dividend on Wednesday, July 31st. Stockholders of record on Thursday, October 3rd will be paid a dividend of GBX 0.14 per share on Wednesday, October 30th. This represents a dividend yield of 0.62%. The ex-dividend date of this dividend is Thursday, October 3rd. The official announcement can be seen at this link. View Smith & Nephew's Dividend History.

Smith & Nephew is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for Smith & Nephew.

9 analysts have issued 1 year price objectives for Smith & Nephew's shares. Their forecasts range from GBX 1,670 to GBX 2,325. On average, they anticipate Smith & Nephew's stock price to reach GBX 1,898.50 in the next year. This suggests that the stock has a possible downside of 5.5%. View Analyst Price Targets for Smith & Nephew.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Smith & Nephew.

News articles about SN stock have trended negative on Thursday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Smith & Nephew earned a coverage optimism score of -2.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 9.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Smith & Nephew.

Some companies that are related to Smith & Nephew include Corindus Vascular Robotics (CVRS), Consort Medical (CSRT), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), LiDCO Group (LID), Deltex Medical Group (DEMG), InspireMD (NSPR), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Imperial Brands (IMB), Smith & Nephew (SNN), Alexion Pharmaceuticals (ALXN), Barclays (BARC), GlaxoSmithKline (GSK), Anglo American (AAL), Aviva (AV), AstraZeneca (AZN), BAE Systems (BA) and British American Tobacco Plc Ads (BATS).

Shares of SN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of SN stock can currently be purchased for approximately GBX 2,009.

Smith & Nephew has a market capitalization of £17.58 billion and generates £4.95 billion in revenue each year. Smith & Nephew employs 16,377 workers across the globe.View Additional Information About Smith & Nephew.

The official website for Smith & Nephew is http://www.smith-nephew.com/.

Smith & Nephew's mailing address is 15 Adam Street, LONDON, WC2N 6LA, United Kingdom. The company can be reached via phone at +44-20-74017646.